Advertisement

Journal of Neurology

, Volume 253, Supplement 1, pp i3–i9 | Cite as

Autonomic dysfunction in multiple sclerosis

  • Carl-Albrecht HaenschEmail author
  • Johannes Jörg
Article

Abstract

Multiple sclerosis (MS) is the most frequent chronic neurological disease affecting young persons in developed countries. MS is, however, considered as a secondary cause, of central origin, for autonomic dysfunction. The most common autonomic symptoms in MS are disorders of micturation, impotence, sudomotor and gastrointestinal disturbances, orthostatic intolerance as well as sleep disorders. The majority of the patients suffer at some period of the disease from lower urinary tract symptoms and sexual dysfunction.Awareness and treatment of these conditions is vital to improving health and quality of life in patients with MS. The increased understanding of the pathophysiological mechanisms in autonomic dysfunction in MS, along with technological and pharmaceutical developments has advanced our ability to treat the multiple aspects complicating autonomic failure in MS.

Key words

autonomic dysfunction multiple sclerosis bladder dysfunction sleep gastrointestinal disturbances 

References

  1. 1.
    (1992) Impotence. NIH Consens Statement 10:1–33Google Scholar
  2. 2.
    (1993) NIH Consensus Conference. Impotence. NIH Consensus Development Panel on Impotence. Jama 270:83–90Google Scholar
  3. 3.
    Acevedo AR, Nava C, Arriada N, Violante A, Corona T (2000) Cardiovascular dysfunction in multiple sclerosis. Acta Neurol Scand 101:85–88CrossRefPubMedGoogle Scholar
  4. 4.
    Apostolidis AN, Fowler CJ (2003) Evaluation and treatment of autonomic disorders of the urogenital system. Semin Neurol 23:443–452PubMedGoogle Scholar
  5. 5.
    Araki I, Matsui M, Ozawa K, Nishimura M, Kuno S, Saida T (2002) Relationship between urinary symptoms and disease-related parameters in multiple sclerosis. J Neurol 249:1010–1015CrossRefPubMedGoogle Scholar
  6. 6.
    Araki I, Matsui M, Ozawa K, Takeda M, Kuno S (2003) Relationship of bladder dysfunction to lesion site in multiple sclerosis. J Urol 169:1384–1387CrossRefPubMedGoogle Scholar
  7. 7.
    Bakshi R (2003) Fatigue associated with multiple sclerosis: diagnosis, impact and management. Mult Scler 9:219–227CrossRefPubMedGoogle Scholar
  8. 8.
    Bateman AM, Goldish GD (2002) Autonomic dysreflexia in multiple sclerosis. J Spinal Cord Med 25:40–42PubMedGoogle Scholar
  9. 9.
    Bilinska M, Pokryszko A, Gruszka E, Piechocki DW (1998) Evaluation of sweating function, changes in heart function and postural blood pressure in patients with multiple sclerosis. Pol Merkuriusz Lek 4:150–153PubMedGoogle Scholar
  10. 10.
    Blackmer J (2003) Rehabilitation medicine: 1. Autonomic dysreflexia. Cmaj 169:931–935PubMedGoogle Scholar
  11. 11.
    Bosma R, Wynia K, Havlikova E, De Keyser J, Middel B (2005) Efficacy of desmopressin in patients with multiple sclerosis suffering from bladder dysfunction: a meta-analysis. Acta Neurol Scand 112:1–5CrossRefPubMedGoogle Scholar
  12. 12.
    Caminero AB, Perez-Jimenez A, Barreiro P, Ferrer T (1995) Sympathetic skin response: correlation with autonomic and somatic involvement in multiple sclerosis. Electromyogr Clin Neurophysiol 35:457–462PubMedGoogle Scholar
  13. 13.
    Chokroverty S (1999) Sleep and the autonomic nervous system. In: Vinken PJ, Bruyn GW, Appenzeller O (eds) Handbook of Clinical Neurology: The Autonomic Nervous System. Part I Normal Functions. Elsevier, Amsterdam; New York, pp 523–570Google Scholar
  14. 14.
    Culebras A (2000) Sleep disorders and neurological disease. M. Dekker, New YorkGoogle Scholar
  15. 15.
    Cvetkovic RS, Plosker GL (2005) Desmopressin: in adults with nocturia. Drugs 65:99–107; discussion 108–109PubMedGoogle Scholar
  16. 16.
    Davis SL, Wilson TE, Vener JM, Crandall CG, Petajan JH, White AT (2005) Pilocarpine-induced sweat gland function in individuals with multiple sclerosis. J Appl Physiol 98:1740–1744PubMedGoogle Scholar
  17. 17.
    de Seze J, Arndt C, Stojkovic T, Ayachi M, Gauvrit JY, Bughin M, Saint Michel T, Pruvo JP, Hache JC, Vermersch P (2001) Pupillary disturbances in multiple sclerosis: correlation with MRI findings. J Neurol Sci 188:37–41CrossRefPubMedGoogle Scholar
  18. 18.
    Dewis ME, Thornton NG (1989) Sexual dysfunction in multiple sclerosis. J Neurosci Nurs 21:175–179PubMedGoogle Scholar
  19. 19.
    Drory VE, Nisipeanu PF, Kroczyn AD (1995) Tests of autonomic dysfunction in patients with multiple sclerosis. Acta Neurol Scand 92:356–360PubMedGoogle Scholar
  20. 20.
    el-Maghraby TA, Shalaby NM, Al-Tawdy MH, Salem SS (2005) Gastric motility dysfunction in patients with multiple sclerosis assessed by gastric emptying scintigraphy. Can J Gastroenterol 19:141–145PubMedGoogle Scholar
  21. 21.
    Elie B, Louboutin JP (1995) Sympathetic skin response (SSR) is abnormal in multiple sclerosis. Muscle Nerve 18:185–189CrossRefPubMedGoogle Scholar
  22. 22.
    Ferini-Strambi L, Filippi M, Martinelli V, Oldani A, Rovaris M, Zucconi M, Comi G, Smirne S (1994) Nocturnal sleep study in multiple sclerosis: correlations with clinical and brain magnetic resonance imaging findings. J Neurol Sci 125:194–197PubMedGoogle Scholar
  23. 23.
    Fernandez O (2002) Mechanisms and current treatments of urogenital dysfunction in multiple sclerosis. J Neurol 249:1–8PubMedGoogle Scholar
  24. 24.
    Fernández O (2000) Urogenital dysfunction in multiple sclerosis. In: 10th Meeting of the European Neurological Society. Jerusalem, IsraelGoogle Scholar
  25. 25.
    Flachenecker P, Rufer A, Bihler I, Hippel C, Reiners K, Toyka KV, Kesselring J (2003) Fatigue in MS is related to sympathetic vasomotor dysfunction. Neurology 61:851–853PubMedGoogle Scholar
  26. 26.
    Fowler CJ, Miller JR, Sharief MK, Hussain IF, Stecher VJ, Sweeney M (2005) A double blind, randomised study of sildenafil citrate for erectile dysfunction in men with multiple sclerosis. J Neurol Neurosurg Psychiatry 76:700–705CrossRefPubMedGoogle Scholar
  27. 27.
    Fowler CJ, van Kerrebroeck PE, Nordenbo A, Van Poppel H (1992) Treatment of lower urinary tract dysfunction in patients with multiple sclerosis. Committee of the European Study Group of SUDIMS (Sexual and Urological Disorders in Multiple Sclerosis). J Neurol Neurosurg Psychiatry 55:986–989PubMedGoogle Scholar
  28. 28.
    Gupta P HW, Rahman K, Walters A, Chokroverty S (1996) Periodic limb movements (PLMs) in a patient with multiple sclerosis and central sleep apnea: independent right and left leg movement periods suggest lateralized PLM oscillators. Sleep Res 25:417Google Scholar
  29. 29.
    Happe S (2003) Excessive daytime sleepiness and sleep disturbances in patients with neurological diseases: epidemiology and management. Drugs 63:2725–2737CrossRefPubMedGoogle Scholar
  30. 30.
    Hinds JP, Eidelman BH, Wald A (1990) Prevalence of bowel dysfunction in multiple sclerosis.A population survey. Gastroenterology 98:1538–1542PubMedGoogle Scholar
  31. 31.
    Kragt JJ, Hoogervorst EL, Uitdehaag BM, Polman CH (2004) Relation between objective and subjective measures of bladder dysfunction in multiple sclerosis. Neurology 63:1716–1718PubMedGoogle Scholar
  32. 32.
    Krupp LB (2003) Fatigue in multiple sclerosis: definition, pathophysiology and treatment. CNS Drugs 17:225–234CrossRefPubMedGoogle Scholar
  33. 33.
    Krupp LB, Christodoulou C (2001) Fatigue in multiple sclerosis. Curr Neurol Neurosci Rep 1:294–298PubMedGoogle Scholar
  34. 34.
    Kurz A, Sessler DI, Tayefeh F, Goldberger R (1998) Poikilothermia syndrome. J Intern Med 244:431–436CrossRefPubMedGoogle Scholar
  35. 35.
    Lee MS, Choi YC, Lee SH, Lee SB (1996) Sleep-related periodic leg movements associated with spinal cord lesions. Mov Disord 11:719–722CrossRefPubMedGoogle Scholar
  36. 36.
    Linden D, Diehl RR, Berlit P (1995) Subclinical autonomic disturbances in multiple sclerosis. J Neurol 242:374–378CrossRefPubMedGoogle Scholar
  37. 37.
    Linden D, Diehl RR, Kretzschmar A, Berlit P (1997) Autonomic evaluation by means of standard tests and power spectral analysis in multiple sclerosis. Muscle Nerve 20:809–814CrossRefPubMedGoogle Scholar
  38. 38.
    Lopez G (1999) Sexual function, dysfunction, orientation and the autonomic nervous system. In: Appenzeller O (ed) The autonomic nervous system. Part II. Dysfunctions. Handbook of clinical neurology. Elsevier, Amsterdam; New York, pp 84–103Google Scholar
  39. 39.
    Lundberg PO, Brattberg A (1992) Sexual dysfunction in selected neurologic disorders: hypothalamopituitary disorders, epilepsy, myelopathies, polyneuropathies, and sacral nerve lesions. Semin Neurol 12:115–119PubMedGoogle Scholar
  40. 40.
    McAllister TW (2003) The safety and efficacy of modafinil in multiple sclerosis-related fatigue. Curr Psychiatry Rep 5:367Google Scholar
  41. 41.
    Merkelbach S, Dillmann U, Kolmel C, Holz I, Muller M (2001) Cardiovascular autonomic dysregulation and fatigue in multiple sclerosis. Mult Scler 7:320–326CrossRefPubMedGoogle Scholar
  42. 42.
    Nasseri K, TenVoorde BJ, Ader HJ, Uitdehaag BM, Polman CH (1998) Longitudinal follow-up of cardiovascular reflex tests in multiple sclerosis. J Neurol Sci 155:50–54CrossRefPubMedGoogle Scholar
  43. 43.
    Nasseri K, Uitdehaag BM, van Walderveen MA, Ader HJ, Polman CH (1999) Cardiovascular autonomic function in patients with relapsing remitting multiple sclerosis: a new surrogate marker of disease evolution? Eur J Neurol 6:29–33CrossRefPubMedGoogle Scholar
  44. 44.
    Noronha MJ, Vas CJ, Aziz H (1968) Autonomic dysfunction (sweating responses) in multiple sclerosis. J Neurol Neurosurg Psychiatry 31:19–22PubMedGoogle Scholar
  45. 45.
    Pozzessere G, Rossi P, Valle E, Froio CP, Petrucci AF, Morocutti C (1997) Autonomic involvement in multiple sclerosis: a pupillometric study. Clin Auton Res 7:315–319CrossRefPubMedGoogle Scholar
  46. 46.
    Rosenberg JH, Shafor R (2005) Fatigue in multiple sclerosis: a rational approach to evaluation and treatment. Curr Neurol Neurosci Rep 5:140–146PubMedGoogle Scholar
  47. 47.
    Saari A, Tolonen U, Paakko E, Suominen K, Pyhtinen J, Sotaniemi K, Myllyla V (2004) Cardiovascular autonomic dysfunction correlates with brain MRI lesion load in MS. Clin Neurophysiol 115:1473–1478CrossRefPubMedGoogle Scholar
  48. 48.
    Sakakibara R, Mori M, Fukutake T, Kita K, Hattori T (1997) Orthostatic hypotension in a case with multiple sclerosis. Clin Auton Res 7:163–165CrossRefPubMedGoogle Scholar
  49. 49.
    Sanya EO, Tutaj M, Brown CM, Goel N, Neundorfer B, Hilz MJ (2005) Abnormal heart rate and blood pressure responses to baroreflex stimulation in multiple sclerosis patients. Clin Auton Res 15:213–218PubMedGoogle Scholar
  50. 50.
    Singer C (1995) Sexual Dysfunction. In: Korczyn AD (ed) Handbook of autonomic nervous system dysfunction. Neurological disease and therapy; 38. M Dekker, New York, pp 381–397Google Scholar
  51. 51.
    Stankoff B, Waubant E, Confavreux C, Edan G, Debouverie M, Rumbach L, Moreau T, Pelletier J, Lubetzki C, Clanet M (2005) Modafinil for fatigue in MS: a randomized placebo-controlled double-blind study. Neurology 64:1139–1143PubMedGoogle Scholar
  52. 52.
    Tachibana N, Howard RS, Hirsch NP, Miller DH, Moseley IF, Fish D (1994) Sleep problems in multiple sclerosis. Eur Neurol 34:320–323PubMedGoogle Scholar
  53. 53.
    Thomaides TN, Zoukos Y, Chaudhuri KR, Mathias CJ (1993) Physiological assessment of aspects of autonomic function in patients with secondary progressive multiple sclerosis. J Neurol 240:139–143CrossRefPubMedGoogle Scholar
  54. 54.
    Thomas P Leist SG, Karen Hartnett, Bernadette Kalman (2005) Monitoring of Cardiac Function during Mitoxantrone Therapy. In: 57th Annual Meeting AAN. MiamiGoogle Scholar
  55. 55.
    Ueno M, Tokunaga Y, Terachi S, Gondo K, Hara T (2000) Asymmetric sweating in a child with multiple sclerosis. Pediatr Neurol 23:74–76CrossRefPubMedGoogle Scholar
  56. 56.
    Vas CJ (1969) Sexual impotence and some autonomic disturbances in men with multiple sclerosis. Acta Neurol Scand 45:166–182PubMedGoogle Scholar
  57. 57.
    Vita G, Fazio MC, Milone S, Blandino A, Salvi L, Messina C (1993) Cardiovascular autonomic dysfunction in multiple sclerosis is likely related to brainstem lesions. J Neurol Sci 120:82–86CrossRefPubMedGoogle Scholar
  58. 58.
    Waldron DJ, Horgan PG, Patel FR, Maguire R, Given HF (1993) Multiple sclerosis: assessment of colonic and anorectal function in the presence of faecal incontinence. Int J Colorectal Dis 8:220–224CrossRefPubMedGoogle Scholar
  59. 59.
    Zifko UA (2004) Management of fatigue in patients with multiple sclerosis. Drugs 64:1295–1304CrossRefPubMedGoogle Scholar
  60. 60.
    Zifko UA, Rupp M, Schwarz S, Zipko HT, Maida EM (2002) Modafinil in treatment of fatigue in multiple sclerosis. Results of an open-label study. J Neurol 249:983–987CrossRefPubMedGoogle Scholar

Copyright information

© Steinkopff-Verlag 2006

Authors and Affiliations

  1. 1.Dept. of.NeurologyHELIOS Klinikum WuppertalWuppertalGermany

Personalised recommendations